Navigation Links
Blood Protein Level May Not Influence Effectiveness of Statins
Date:1/28/2011

FRIDAY, Jan. 28 (HealthDay News) -- A new study debunks the idea that the cholesterol-fighting drugs known as statins work better in people with high levels of a certain protein and may not work at all in those with low levels.

Researchers found that the drugs work the same -- at least in heart patients, older men with high blood pressure and diabetics -- regardless of the results of a test that looks for concentrations of so-called C-reactive protein.

"The bottom line is, if you have vascular disease or diabetes, you will derive substantial benefit from statin treatment," said Dr. Gregg C. Fonarow, a cardiology professor at the University of California, Los Angeles, who was not involved in the research.

However, Fonarow said, the findings do not say whether levels of the protein will affect the effectiveness of the drugs in healthy people.

According to Fonarow, research suggests that statins reduce the risk for heart disease "events" -- such as a heart attack -- by 24 percent to 52 percent. "The cardiovascular benefits of statins extend to men and women, old and young, and even to patients with baseline LDL-cholesterol levels lower than 100 milligrams per deciliter [mg/dcl]," he said. LDL, or low-density lipoprotein cholesterol, is the type that causes plaque to form, narrowing arteries.

Some research has linked levels of C-reactive protein to better or worse effectiveness. In the new study, researchers in the United Kingdom assigned 20,536 men and women at high risk for heart problems to take either the statin Zocor (simvastatin) or a placebo for an average of five years.

The study, published online Jan. 28 in The Lancet, found no link between levels of the protein and benefits from the drug. Even people with low levels of LDL cholesterol and the protein -- those thought to perhaps be immune to the drug's effects -- showed benefits.

In the big picture, Fonarow said, people shouldn't worry about levels of the protein in their bodies.

"Patients interested in their cardiovascular health should be most focused on achieving healthy LDL-cholesterol, blood pressure and body weight levels along with engaging in daily exercise, eating a healthy diet, not smoking and avoiding secondhand smoke," he said.

The study was partially funded by Merck, which makes Zocor.

More information

The American Heart Association has more about cholesterol.

-- Randy Dotinga

SOURCES: Gregg C. Fonarow, M.D., professor, cardiology, University of California, Los Angeles; Jan. 28, 2011, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Getting more anti-cancer medicine into the blood
2. Small bowel blood flow in healthy subjects receiving low-dose aspirin
3. Ultrasound and a blood test can increase survival after myocardial infarction
4. Global view of blood cell development reveals new and complex circuitry
5. Storytelling may help control blood pressure in African-Americans
6. Some Severe MS Flares Helped by Blood Filtering Treatment
7. Some Antibiotics, Blood Pressure Meds a Bad Mix: Study
8. Blood Type O Associated With Less Risk for Heart Attack
9. Bioactive compounds in berries can reduce high blood pressure
10. Room light before bedtime may impact sleep quality, blood pressure and diabetes risk
11. International research team reports major findings in prevention and treatment of blood clots
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Protein Level May Not Influence Effectiveness of Statins
(Date:2/14/2016)... ... February 14, 2016 , ... ... of Heart Failure Nurses (AAHFN) is promoting healthier living with heart failure by ... of Life! Healthy Living with Heart Failure will kick-off February 14 and includes ...
(Date:2/13/2016)... ... February 13, 2016 , ... ... Voices of Recovery, the leading national organization representing the growing community of recovering ... public office to include Family Recovery in policies addressing addiction. , Although ...
(Date:2/13/2016)... ... February 13, 2016 , ... In ... states that vein visualization technology should be used to ensure patient safety when ... world, the INS Standards mandate the use of vein visualization technology in patients ...
(Date:2/13/2016)... ... , ... DDi , a Makro company, makes it ... expertise in eClinical Solutions. DDi has built its solution competency with a unique ... clients. DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by ...
(Date:2/12/2016)... WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH ... for low-resource settings. The partnership will recruit top students from U.S. universities ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
(Date:2/12/2016)... , Feb. 12, 2016 Hypermarcas ... a cash tender offer (the "Tender Offer") to ... outstanding aggregate principal amount of its 6.500% Senior ... ISIN Nos. US44915JAA88/ USP5246AAF05) (the "Notes"). In connection ... (the "Consent Solicitation") consents (the "Consents") of the ...
(Date:2/12/2016)... -- Innophos Holdings, Inc. (NASDAQ: IPHS ), a leading international ... it will host a live conference call on Tuesday, February ... quarter and full year 2015 results. ... quarter and full year results will be issued on Monday, ... --> --> The conference call can be ...
Breaking Medicine Technology: